Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Edwards Lifesciences Corp (EW)

1K + Investors. Track Smart Money conviction in EW. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +39
Streak
1Q ▲
Buyers last Q
52%

Smart Money Signals — EW

Based on 1328 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added EW than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
1,328 hedge funds hold EW right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +7% more funds vs a year ago

fund count last 6Q
+85 new funds entered over the past year (+7% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 52% buying

652 buying605 selling
Last quarter: 652 funds bought or added vs 605 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+56 vs last Q)

new funds entering per quarter
Funds opening a new EW position: 124 → 191 → 121 → 177. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

70% of holders stayed for 2+ years

■ 70% conviction (2yr+) ■ 15% medium ■ 15% new
929 out of 1,328 hedge funds have held EW for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
➡️

Steady discovery — ~177 new funds/quarter

175 → 124 → 191 → 121 → 177 new funds/Q
New funds entering each quarter: 124 → 191 → 121 → 177. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 73% veterans vs 17% newcomers

■ 73% veterans ■ 10% 1-2yr ■ 17% new
Entry-cohort mix of 1,358 holders: 987 (73%) are 2+ year veterans, 136 entered 1–2 years ago, and 235 (17%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 57% AUM from top-100 funds

57% from top-100 AUM funds
65 of 1322 holders are among the 100 largest funds by AUM, controlling 57% of total institutional value in EW. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.4
out of 10
Low Exit Risk
Exit risk score 3.4/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — EW

In 2026 Q2, 652 hedge funds were net buyers of EW (177 opened a new position, 475 added to an existing one), while 605 reduced or exited (467 trimmed, 138 sold completely) — a 52% buyer ratio, indicating a slight buying edge. 57% of total institutional value in EW is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +39 funds (more new holders than closures). Total institutional holders: 1328.

Hedge Fund Ownership: EW

How many hedge funds hold EW — quarterly history vs. share price
Quarterly hedge fund ownership of EW vs. share price

Market Analysis: EW

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: EW

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Edwards Lifesciences Corp (EW) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much EW has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 78d ago
EW
-1.8%
XLV
+5.7%

EW outperformed XLV by -7.5% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 33d ago
EW
-3.0%
XLV
+0.2%

Since the filing became public, EW outperformed XLV by -3.2% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

39 top-rated funds 7 high-conviction
Consensus
7.0
/ 10
breadth
×
Elite
3.7
/ 10
conviction
Hedge Fund Positioning: EW
1K + Investors

Track Smart Money conviction in EW. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 1314 1289 1.94%
13F Shares 522M 423M 23.6%
Total Value $45.99B $32.67B 40.76%
New Positions 175 121 +54
Increased Positions 457 458 -1
Closed Positions 144 139 +5
Reduced Positions 456 447 +9
Total Calls 17 21 -19.05%
Total Puts 19 28 -32.14%
PUT/CALL Ratio 1.12 1.33 Neutral

Statistics: EW

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

1K + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in EW. Verified SEC 13F-HR filings.

QUARTER:
Top 25 EW holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 2Xideas AG 13.27% 340,806 $30.8M
2 Seilern Investment Management Ltd 6.84% 600,231 $54.3M
3 Wormser Freres Gestion 4.83% 90,770 $8.5M
4 WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 4.82% 4,800,000 $434.2M
5 Wilson Asset Management (international) Pty Ltd 3.60% 144,918 $13.1M
6 Meridiem Capital Partners LP 3.48% 858,921 $77.7M
7 Titan Wealth (CI) Ltd 3.42% 101,900 $9.2M
8 Haven Capital Group, Inc. 3.19% 43,932 $4.0M
9 Manitou Investment Management Ltd. 3.19% 189,563 $17.1M
10 Wedgewood Partners Inc 3.08% 165,208 $14.9M
11 Triodos Investment Management BV 2.72% 493,358 $44.6M
12 Birch Hill Investment Advisors LLC 2.69% 735,377 $66.5M
13 Ninety One North America, Inc. 2.61% 616,498 $55.8M
14 Atle Fund Management AB 2.51% 103,230 $9.3M
15 Ninety One UK Ltd 2.50% 12,337,502 $1.12B
16 Mirova US LLC 2.47% 2,540,381 $229.8M
17 Fulcrum Capital LLC 2.41% 131,371 $11.9M
18 Nantahala Capital Management, LLC 2.41% 800,000 $72.4M
19 Integral Health Asset Management, LLC 2.23% 625,000 $56.5M
20 Rhenman & Partners Asset Management AB 2.22% 260,000 $23.5M
21 Catalio Capital Management, LP 2.12% 124,778 $11.3M
22 PFM Health Sciences, LP 1.94% 250,453 $22.7M
23 Aristotle Capital Management, LLC 1.64% 8,665,712 $783.9M
24 Liontrust Investment Partners LLP 1.62% 1,216,379 $110.0M
25 Nan Shan Life Insurance Co., Ltd. 1.57% 552,221 $50.0M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Edwards Lifesciences Corp (EW)

What does the Smart Money Trend signal show for EW?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added EW than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for EW?

Slight buying edge — 52% buying: Last quarter: 652 funds bought or added vs 605 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for EW holders?

Elite ownership — 57% AUM from top-100 funds: 65 of 1322 holders are among the 100 largest funds by AUM, controlling 57% of total institutional value in EW. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held EW?

70% of holders stayed for 2+ years: 929 out of 1,328 hedge funds have held EW for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Edwards Lifesciences Corp (EW) following the 2026 Q2 hedge fund 13F filings?

As of today, EW has moved -3.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.2% for the XLV sector ETF — an outperformance of -3.2%. Since the quarter end (June 30, 2026), EW has gained -1.8% vs +5.7% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →